Table 2 Outcomes in the 322-patient prospective cohort and correlation with GEP class, SLN status, and ulceration
Recurrence (n* = 25) | Distant metastasis (n = 12) | Death (n = 11) | |
|---|---|---|---|
Class 1 (n = 248) | 5 (2%) | 2 (1%) | 3 (1%) |
Class 2 (n = 74) | 20 (27%) | 10 (14%) | 8 (11%) |
p value** | <0.0001 | <0.0001 | 0.0001 |
SLN− (n = 286) | 15 (5%) | 6 (2%) | 10 (3%) |
SLN+ (n = 36) | 10 (28%) | 6 (17%) | 1 (3%) |
p value | <0.0001 | <0.001 | 1 |
Ulceration absent (n = 264) | 10 (4%) | 3 (1%) | 6 (2%) |
Ulceration present (n = 58) | 15 (26%) | 9 (16%) | 5 (9%) |
p value | <0.0001 | <0.0001 | 0.04 |